T1	DISO 105 120	tumores sólidos
#1	AnnotatorNotes T1	C0280100; Solid Neoplasm; Neoplastic Process
T2	CHEM 162 170	Olaparib
#2	AnnotatorNotes T2	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T3	PROC 199 233	Análisis retrospectivo/prospectivo
T4	PROC 297 308	tratamiento
#3	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 325 340	tumores sólidos
#4	AnnotatorNotes T5	C0280100; Solid Neoplasm; Neoplastic Process
T6	DISO 363 378	tumor de ovario
T7	ANAT 414 420	ovario
#5	AnnotatorNotes T7	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T8	PROC 450 461	Tratamiento
#6	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 482 490	olaparib
#7	AnnotatorNotes T9	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T10	PROC 497 511	ensayo clínico
#8	AnnotatorNotes T10	C0008976; Clinical Trials; Research Activity
T11	PROC 526 541	atención médica
#9	AnnotatorNotes T11	C0496675; Medical care; Health Care Activity
T12	DISO 404 420	cáncer de ovario
#10	AnnotatorNotes T12	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T13	PROC 571 583	tratamientos
#11	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	DISO 624 650	cáncer epitelial de ovario
#12	AnnotatorNotes T14	C0677886; Epithelial ovarian cancer; Neoplastic Process
T15	DISO 664 705	cáncer de trompas de Falopio o peritoneal
#13	AnnotatorNotes T15	C0153579; Malignant neoplasm of fallopian tube; Neoplastic Process | C0153467; Malignant tumor of peritoneum; Neoplastic Process
T16	ANAT 695 705	peritoneal
#14	AnnotatorNotes T16	C0031153; Peritoneum; Tissue | C0442034; peritoneal; Body Location or Region
T17	CHEM 710 718	olaparib
#15	AnnotatorNotes T17	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T18	CHEM 730 736	agente
#16	AnnotatorNotes T18	C0450442; Agent; Chemical Viewed Functionally
T19	DISO 755 765	enfermedad
#17	AnnotatorNotes T19	C0012634; Disease; Disease or Syndrome
T20	CHEM 788 796	olaparib
#18	AnnotatorNotes T20	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T21	CHEM 808 814	agente
#19	AnnotatorNotes T21	C0450442; Agent; Chemical Viewed Functionally
T22	PROC 833 861	tratamiento de mantenimiento
#20	AnnotatorNotes T22	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T23	PROC 888 901	quimioterapia
#21	AnnotatorNotes T23	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T24	CHEM 912 919	platino
#22	AnnotatorNotes T24	C0032207; platinum; Element, Ion, or Isotope
T25	CHEM 930 938	olaparib
#23	AnnotatorNotes T25	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T26	PROC 953 966	quimioterapia
#24	AnnotatorNotes T26	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T27	CHEM 977 984	platino
#25	AnnotatorNotes T27	C0032207; platinum; Element, Ion, or Isotope
T28	PROC 1003 1031	tratamiento de mantenimiento
#26	AnnotatorNotes T28	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T29	CHEM 1041 1049	olaparib
#27	AnnotatorNotes T29	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T30	PROC 1079 1090	tratamiento
#28	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	CHEM 1132 1140	olaparib
#29	AnnotatorNotes T31	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T32	CHEM 1193 1201	olaparib
#30	AnnotatorNotes T32	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T33	CHEM 1319 1327	olaparib
#31	AnnotatorNotes T33	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T34	PROC 1355 1369	ensayo clínico
#32	AnnotatorNotes T34	C0008976; Clinical Trials; Research Activity
T35	PROC 1478 1502	consentimiento informado
#33	AnnotatorNotes T35	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T36	PROC 1384 1399	atención médica
#34	AnnotatorNotes T36	C0496675; Medical care; Health Care Activity
T37	PROC 1589 1611	pruebas de laboratorio
#35	AnnotatorNotes T37	C0022885; Laboratory Procedures; Laboratory Procedure
T38	PROC 1620 1634	procedimientos
#36	AnnotatorNotes T38	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T39	DISO 1687 1718	trastorno médico o psiquiátrico
T40	PROC 1823 1830	biopsia
#37	AnnotatorNotes T40	C0005558; Biopsy; Diagnostic Procedure
T41	CHEM 313 321	olaparib
#38	AnnotatorNotes T41	C2316164; olaparib; Organic Chemical · Pharmacologic Substance
T42	ANAT 372 378	ovario
#39	AnnotatorNotes T42	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T43	ANAT 631 640	epitelial
#40	AnnotatorNotes T43	C0014609; Epithelium; Tissue
T44	ANAT 644 650	ovario
#41	AnnotatorNotes T44	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T45	ANAT 674 692	trompas de Falopio
#42	AnnotatorNotes T45	C0015560; Fallopian Tubes; Body Part, Organ, or Organ Component | C1278991;Entire fallopian tube ; Body Part, Organ, or Organ Component
T46	Date 12 16	2017
T47	LIVB 91 100	pacientes
#43	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Date 144 157	a largo plazo
T49	LIVB 256 265	pacientes
#44	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Date 280 293	a largo plazo
T51	Date 471 477	actual
T53	LIVB 1094 1102	Personas
#45	AnnotatorNotes T53	C0027361; Persons; Population Group
T54	LIVB 1152 1161	pacientes
#46	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Duration 1210 1220	≥ 18 meses
T56	LIVB 1232 1248	grupo de control
#47	AnnotatorNotes T56	C0009932; Control Group; Group
T57	LIVB 1259 1268	pacientes
#48	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Duration 1297 1314	de corta duración
T59	Duration 1331 1347	menos de 6 meses
T60	PHYS 1430 1438	entender
#49	AnnotatorNotes T60	C0162340; Comprehension; Mental Process
T62	LIVB 1534 1542	paciente
#50	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Duration 1734 1741	crónico
#51	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T65	LIVB 1793 1801	paciente
#52	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	Neg_cue 1802 1804	no
T67	LIVB 1834 1879	Mujeres embarazadas o en período de lactancia
#53	AnnotatorNotes T67	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T52	PHYS 1842 1853	embarazadas
#54	AnnotatorNotes T52	C0032961; Pregnancy; Organism Function
T61	PHYS 1870 1879	lactancia
#55	AnnotatorNotes T61	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T64	PROC 1564 1571	visitas
#56	AnnotatorNotes T64	C1512346; Patient Visit; Health Care Activity
A1	Assertion T40 Negated
A2	Status T8 History_of
A3	Status T23 History_of
A4	Status T24 History_of
#57	AnnotatorNotes T3	C0033522; Prospective Studies; Research Activity + C0035363; Retrospective Studies; Research Activity
#58	AnnotatorNotes T50	C0443252; Long-term; Temporal Concept
#59	AnnotatorNotes T48	C0443252; Long-term; Temporal Concept
#60	AnnotatorNotes T51	C0521116; Current (present time); Temporal Concept 
#61	AnnotatorNotes T39	C0012634; Disease; Disease or Syndrome + C0004936; Mental disorders; Mental or Behavioral Dysfunction 
#62	AnnotatorNotes T6	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T68	Observation 1809 1813	apto
A5	Assertion T68 Negated
R1	Negation Arg1:T66 Arg2:T68	
#63	AnnotatorNotes T68	C3242266; patient not eligible; Finding (?)
R2	Experiences Arg1:T47 Arg2:T1	
R3	Experiences Arg1:T47 Arg2:T2	
T69	Observation 134 143	beneficio
R4	Overlap Arg1:T69 Arg2:T48	
R5	Overlap Arg1:T69 Arg2:T2	
R6	Experiences Arg1:T47 Arg2:T69	
R7	Experiences Arg1:T49 Arg2:T4	
T70	Observation 270 279	responden
#64	AnnotatorNotes T70	C1319171; Medication response; Finding
R8	Experiences Arg1:T49 Arg2:T70	
R9	Overlap Arg1:T70 Arg2:T50	
R10	Used_for Arg1:T41 Arg2:T4	
R11	Experiences Arg1:T49 Arg2:T5	
R12	Overlap Arg1:T70 Arg2:T41	
R13	Location_of Arg1:T42 Arg2:T6	
R14	Location_of Arg1:T7 Arg2:T12	
R15	Used_for Arg1:T9 Arg2:T8	
R16	Overlap Arg1:T9 Arg2:T51	
R17	Used_for Arg1:T9 Arg2:T13	
R18	Location_of Arg1:T43 Arg2:T14	
R19	Location_of Arg1:T44 Arg2:T14	
R20	Location_of Arg1:T45 Arg2:T15	
R21	Location_of Arg1:T16 Arg2:T15	
T71	Quantifier_or_Qualifier 724 729	único
#65	AnnotatorNotes T71	C0205171; Singular; Quantitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T71	
T72	Quantifier_or_Qualifier 802 807	único
#66	AnnotatorNotes T72	C0205171; Singular; Quantitative Concept
R23	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T72	
T73	Observation 766 777	recidivante
#67	AnnotatorNotes T73	C2825055; Recurrence (disease attribute); Pathologic Function
R24	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T73	
R25	Used_for Arg1:T20 Arg2:T22	
T74	Observation 876 885	respuesta
R26	After Arg1:T22 Arg2:T74	
R27	Used_for Arg1:T24 Arg2:T23	
R28	After Arg1:T22 Arg2:T23	
R29	Overlap Arg1:T74 Arg2:T23	
#68	AnnotatorNotes T74	C1319171; Medication response; Finding
R30	Combined_with Arg1:T25 Arg2:T26	
R31	Used_for Arg1:T27 Arg2:T26	
R32	Used_for Arg1:T25 Arg2:T28	
R33	Before Arg1:T26 Arg2:T28	
R34	Used_for Arg1:T29 Arg2:T30	
T75	Quantifier_or_Qualifier 1064 1075	otros tipos
R35	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T75	
T76	Quantifier_or_Qualifier 1121 1129	duradera
#69	AnnotatorNotes T76	C0449238; Duration (temporal concept); Temporal Concept
T77	Observation 1111 1120	respuesta
#70	AnnotatorNotes T77	C1319171; Medication response; Finding
R36	Has_Quantifier_or_Qualifier Arg1:T77 Arg2:T76	
R37	Overlap Arg1:T77 Arg2:T31	
R38	Experiences Arg1:T53 Arg2:T77	
R39	Experiences Arg1:T53 Arg2:T31	
T78	Observation 1179 1189	beneficios
R40	Experiences Arg1:T54 Arg2:T78	
R41	Has_Duration_or_Interval Arg1:T78 Arg2:T55	
R42	Experiences Arg1:T54 Arg2:T32	
R43	Overlap Arg1:T78 Arg2:T32	
R44	Experiences Arg1:T53 Arg2:T78	
R45	Experiences Arg1:T53 Arg2:T32	
R46	Experiences Arg1:T54 Arg2:T77	
R47	Experiences Arg1:T54 Arg2:T31	
T79	Observation 1286 1296	beneficios
R48	Experiences Arg1:T57 Arg2:T79	
R49	Experiences Arg1:T56 Arg2:T79	
R50	Has_Duration_or_Interval Arg1:T79 Arg2:T58	
R51	Experiences Arg1:T56 Arg2:T33	
R52	Experiences Arg1:T57 Arg2:T33	
R53	Has_Duration_or_Interval Arg1:T79 Arg2:T59	
R54	Experiences Arg1:T56 Arg2:T36	
R55	Experiences Arg1:T57 Arg2:T36	
T80	Observation 1441 1449	voluntad
#71	AnnotatorNotes T80	C0600109; Willing; Finding
R56	Overlap Arg1:T80 Arg2:T35	
T81	Observation 1415 1438	Capacidad para entender
R57	Overlap Arg1:T81 Arg2:T35	
R58	Overlap Arg1:T60 Arg2:T35	
T82	Observation 1507 1515	Voluntad
#72	AnnotatorNotes T82	C0600109; Willing; Finding
R59	Overlap Arg1:T82 Arg2:T64	
R60	Overlap Arg1:T82 Arg2:T37	
R61	Overlap Arg1:T82 Arg2:T38	
T83	Observation 1518 1527	capacidad
#73	AnnotatorNotes T83	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R62	Overlap Arg1:T83 Arg2:T64	
R63	Overlap Arg1:T83 Arg2:T37	
R64	Overlap Arg1:T83 Arg2:T38	
R65	Has_Quantifier_or_Qualifier Arg1:T65 Arg2:T68	
R66	Experiences Arg1:T65 Arg2:T39	
T84	Quantifier_or_Qualifier 1719 1724	grave
#74	AnnotatorNotes T84	C1547227; Severe - Severity of Illness Code; Intellectual Product
R67	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T84	
R68	Has_Duration_or_Interval Arg1:T39 Arg2:T63	
T85	Quantifier_or_Qualifier 1726 1731	agudo
#75	AnnotatorNotes T85	C0439557; Acute phase; Temporal Concept
R69	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T85	
T86	Observation 1745 1768	anomalía de laboratorio
#76	AnnotatorNotes T86	C3648370; laboratory tests nonspecific abnormal findings; Finding
R70	Has_Quantifier_or_Qualifier Arg1:T65 Arg2:T86	
R71	Before Arg1:T39 Arg2:T68	
R72	Before Arg1:T86 Arg2:T68	
R73	Experiences Arg1:T67 Arg2:T52	
R74	Experiences Arg1:T67 Arg2:T61	
R75	Experiences Arg1:T65 Arg2:T40	
R76	Before Arg1:T39 Arg2:T40	
R77	Before Arg1:T86 Arg2:T40	
#77	AnnotatorNotes T69	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#78	AnnotatorNotes T78	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#79	AnnotatorNotes T79	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R78	Experiences Arg1:T62 Arg2:T64	
R79	Experiences Arg1:T62 Arg2:T37	
R80	Experiences Arg1:T62 Arg2:T38	
R81	Overlap Arg1:T68 Arg2:T40	
#80	AnnotatorNotes T81	C1273101; Ability to comprehend; Finding
A6	Experiencer T47 Patient
A7	Experiencer T49 Patient
A8	Experiencer T53 Patient
A9	Experiencer T54 Patient
A10	Experiencer T56 Patient
A11	Experiencer T57 Patient
A12	Experiencer T62 Patient
A13	Experiencer T65 Patient
A14	Experiencer T67 Patient
